Recurrent locally advanced breast cancer: The treatment of chest wall disease with further chemotherapy

Clinical Oncology

Volumn 13, Issue 3, 2001, Pages 195-199

  Saunders, Y ^a   Stebbing, J ^a   Broadley, K ^a   Johnston, S R D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chemotherapy; Locally advanced breast cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; VINBLASTINE;

ADVANCED CANCER; ALOPECIA; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; THORAX WALL DEFECT;

EID: 0034948486     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9252     Document Type: Article

References (26)

1. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998;352:30-42.
2. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-67.
3. Esteva FJ, Hortobagyi GN. Locally advanced breast cancer. Hematol Oncol Clin North Am 1999;13:457-72.
4. Pierce LJ, Lichter AS, Archer P. Indications, integration and technical aspects of local-regional irradiation in the management of advanced breast cancer. Semin Radiat Oncol 1994;4:242-53.
5. Newman LA, Kuerer HM, Hunt KK, et al. Feasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol 1999;6:671-5.
6. Halpern J, McNeese MD, Kroll SS, et al. Irradiation of prosthetically augmented breasts: a retrospective study on toxicity and cosmetic results. Int J Radiat Oncol Biol Phys 1990;18:189-91.
7. Rosato RM, Dowden RV. Radiation therapy as a cause of capsular contracture. Ann Plast Surg 1994;32:342-5.
8. Dow K. A review of late effects of cancer in women. Semin Oncol Nurs 1995;11:128-36.
9. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
10. European Organisation for Research and Treatment of Cancer (EORTC). A practical guide to EORTC studies. Brussels, Belgium: EORTC Data Center, 1996:126.
11. Fossati R, Confalonieri C, Torri V, et al. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomised trials involving 31 510 women. J Clin Oncol 1998;16:3439-60.
12. Dauphin S, Katz S, el Tamer M, et al. Chemotherapy is a safe and effective initial therapy for infected malignant breast and chest wall ulcers. J Surg Oncol 1997;66:186-8.
13. Blumenschein GR, DiStefano A, Carderao J, et al. Multimodality therapy for locally advanced and limited Stage IV breast cancer: the impact of non-cross-resistant late-consolidation therapy. Clin Cancer Res 1997;3:2633-7.
14. Rubens RD, Bajetta E, Bonneterre J, et al. Treatment of relapse of breast cancer after adjuvant systemic therapy. Eur J Cancer 1994;30A:106-11.
15. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18. J Clin Oncol 1997;15:2483-93.
16. McMasters KM, Hunt KK. Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life. J Clin Oncol 1999;17:441-4.
17. Mauriac L, MacGrogan G, Avril A, et al. Neoadjuvant chemotherapy for operable breast carcinoma greater than 3 cm: a unicentre randomised trial with a 124 month median follow-up. Ann Oncol 1999;10:47-52.
18. Scoll SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours too large for breast conserving surgery: preliminary results of a randomised trial. Eur J Cancer 1994;30A:645-52.
19. Makris A, Powles TJ, Ashley S, et al. A reduction in requirements in a randomised trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998;9:1179-84.
20. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85.
21. Stebbing J, Smith IE. Preoperative chemotherapy. In: Nabholtz JM, Tonkin K, Aapro M, et al. editors. Breast cancer management application of evidence to patient care. London, UK: Dunitz, 2000:451-68.
22. Bernhard J, Thurlimann B, Schmitz SF, et al. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? J Clin Oncol 1999;17:1672-9.
23. Baum M, Priestman T, West RR, et al. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. In: Mouridsen HT, Palshof T, editors. Breast cancer - experimental and clinical methods. London: Pergamon, 1980:223-8.
24. Geels P, Eisenhauer E, Bezjak A, et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol. 2000;18:2395-405.
25. Van Leeuwen BL, Houwerzijl M, Hoekstra HJ. Educational tips in the treatment of malignant ulcerating tumours of the skin. Eur J Surg Oncol 2000;26:506-8.
26. Cancer pain relief and palliative care. (World Health Organization Technical Report) Geneva, Switzerland: WHO, 1990:804.